直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Federal Circuit Reverses Eligibility of Software Claims Where Technical Improvements Were Not Reflected in Claims

April 15, 2026

Authored and Edited by Christine M. Akagi; Ryan V. McDonnell; Erik R. Puknys

In The Trustees of Columbia University in the City of New York v. Gen Digital Inc., No. 2024-1243 (Fed. Cir. Mar. 11, 2026), the Federal Circuit vacated an infringement judgment, reversed a district court’s determination that the claims of the asserted patents were not directed to an abstract idea, and remanded for further proceedings on patent eligibility.

Columbia sued Gen Digital, the maker of Norton software, for infringement of patents relating to computer security. Gen Digital moved for judgment on the pleadings, arguing that the claims were patent-ineligible under 35 U.S.C. § 101. The district court denied the motion because it determined that the claims were directed not to an abstract idea but to an improvement in computer-virus scanning using multiple computers in a divide-and-conquer approach that improved efficiency. The district court later struck the section 101 defense, and the case proceeded to a jury trial that resulted in a willful infringement verdict and damages award of over $185 million. Gen Digital appealed.

The Federal Circuit reversed the district court’s patent eligibility determination. The Court determined that the claims recited conventional components and that the divide-and-conquer approach and the efficiency gains allegedly associated with it are abstract ideas. Moreover, the Court determined that the technical improvements Columbia asserted were not reflected in the claim language. As a result, the Federal Circuit held that the claims were directed to an abstract idea and remanded for consideration under the second step of the patent-eligibility framework.

Tags

patentable subject matter, 35 U.S.C. § 101, United States Court of Appeals for the Federal Circuit (CAFC)

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Diligence, Licensing, and Opinions

Opinions and Counseling

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Patent Office Invalidation Proceedings

Patent Oppositions and Appeals

Related Industries

AI, Electronics, and Information Technology

Electronic Devices and Components

Electrical and Computer Technology

Related Offices

Palo Alto, CA

Washington, DC

Contacts

Christine M. Akagi
Law Clerk
Washington, DC
+1 202 408 4478
Email
Ryan V. McDonnell
Associate
Washington, DC
+1 202 408 4167
Email
Erik R. Puknys
Partner
Palo Alto, CA
+1 650 849 6644
Email

Copyright © 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP